Strs Ohio Invests $598,000 in National Health Investors, Inc. $NHI

Key Points

• Strs Ohio has initiated a new position in National Health Investors, Inc. (NYSE:NHI) in Q1, purchasing 8,100 shares valued at approximately $598,000.
• The company reported $1.22 earnings per share for the last quarter, surpassing analysts’ expectations of $1.16, indicating a 6.7% year-over-year revenue growth.
• National Health Investors has announced a quarterly dividend increase to $0.92 per share, effective October 31st, representing a 4.7% yield.

Strs Ohio purchased a new stake in National Health Investors, Inc. (NYSE:NHI - Free Report) in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 8,100 shares of the real estate investment trust's stock, valued at approximately $598,000.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Smartleaf Asset Management LLC lifted its holdings in National Health Investors by 49.8% in the 1st quarter. Smartleaf Asset Management LLC now owns 442 shares of the real estate investment trust's stock valued at $33,000 after acquiring an additional 147 shares during the last quarter. GF Fund Management CO. LTD. purchased a new stake in National Health Investors during the fourth quarter valued at about $58,000. Farther Finance Advisors LLC lifted its stake in National Health Investors by 5,000.0% during the first quarter. Farther Finance Advisors LLC now owns 918 shares of the real estate investment trust's stock valued at $68,000 after buying an additional 900 shares in the last quarter. NewEdge Advisors LLC lifted its stake in National Health Investors by 28.7% during the first quarter. NewEdge Advisors LLC now owns 1,546 shares of the real estate investment trust's stock valued at $114,000 after buying an additional 345 shares in the last quarter. Finally, Jupiter Asset Management Ltd. purchased a new stake in National Health Investors during the first quarter valued at about $206,000. 62.51% of the stock is owned by institutional investors and hedge funds.

National Health Investors Stock Performance

Shares of NHI traded up $1.11 during mid-day trading on Tuesday, hitting $79.39. The company's stock had a trading volume of 44,134 shares, compared to its average volume of 242,129. National Health Investors, Inc. has a one year low of $65.13 and a one year high of $85.69. The company has a debt-to-equity ratio of 0.75, a quick ratio of 10.91 and a current ratio of 10.91. The firm has a market capitalization of $3.77 billion, a PE ratio of 25.36, a price-to-earnings-growth ratio of 3.37 and a beta of 0.76. The stock's 50-day moving average is $75.06 and its two-hundred day moving average is $73.77.

National Health Investors (NYSE:NHI - Get Free Report) last posted its quarterly earnings data on Wednesday, August 6th. The real estate investment trust reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.16 by $0.06. National Health Investors had a return on equity of 10.32% and a net margin of 40.97%.The company had revenue of $70.27 million during the quarter, compared to analysts' expectations of $86.46 million. During the same period in the prior year, the business earned $1.18 earnings per share. National Health Investors's revenue for the quarter was up 6.7% compared to the same quarter last year. As a group, sell-side analysts anticipate that National Health Investors, Inc. will post 4.41 EPS for the current year.

National Health Investors Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be given a $0.92 dividend. This is a positive change from National Health Investors's previous quarterly dividend of $0.90. This represents a $3.68 annualized dividend and a dividend yield of 4.6%. The ex-dividend date of this dividend is Tuesday, September 30th. National Health Investors's dividend payout ratio (DPR) is currently 115.02%.

Wall Street Analyst Weigh In

A number of research firms have commented on NHI. KeyCorp raised shares of National Health Investors from a "sector weight" rating to an "overweight" rating and set a $80.00 price objective for the company in a research note on Thursday, July 10th. Wells Fargo & Company upped their price objective on shares of National Health Investors from $76.00 to $80.00 and gave the company an "equal weight" rating in a research note on Wednesday, August 27th. Wedbush raised shares of National Health Investors to a "strong-buy" rating in a research note on Wednesday, July 2nd. Finally, Truist Financial upped their price objective on shares of National Health Investors from $77.00 to $81.00 and gave the company a "buy" rating in a research note on Friday, August 15th. One research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, National Health Investors presently has an average rating of "Buy" and a consensus target price of $84.20.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.